Jeffrey V. Poulton, EVP, Chief Financial Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 7,470 shares at $446.53 ($3.4M) on 2025-10-02, disclosed to the SEC on 2025-10-03.
Open-market sale of $3.4M ALNY by EVP, Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $446.53 | 150 | $67K | 2.0% |
| 2 | $446.53 | 150 | $67K | 2.0% |
| 3 | $447.92 | 73 | $33K | 1.0% |
| 4 | $448.77 | 234 | $105K | 3.1% |
| 5 | $448.77 | 234 | $105K | 3.1% |
| 6 | $449.79 | 324 |
| $146K |
| 4.3% |
| 7 | $449.79 | 324 | $146K | 4.3% |
| 8 | $450.81 | 704 | $317K | 9.4% |
| 9 | $450.81 | 704 | $317K | 9.4% |
| 10 | $451.86 | 432 | $195K | 5.8% |
| 11 | $451.86 | 432 | $195K | 5.8% |
| 12 | $452.69 | 869 | $393K | 11.6% |
| 13 | $452.69 | 869 | $393K | 11.6% |
| 14 | $453.77 | 428 | $194K | 5.8% |
| 15 | $453.77 | 428 | $194K | 5.8% |
| 16 | $454.84 | 317 | $144K | 4.3% |
| 17 | $454.84 | 317 | $144K | 4.3% |
| 18 | $455.82 | 95 | $43K | 1.3% |
| 19 | $457.43 | 191 | $87K | 2.6% |
| 20 | $457.43 | 191 | $87K | 2.6% |
| 21 | $457.64 | 4 | $2K | 0.1% |
| Total | $452.04 avg | 7,470 | $3.4M | 100% |
| Filing → |
| ALNY | SELL | 2026-02-17 | $695K | — | Filing → |
| ALNY | SELL | 2026-01-14 | $1.0M | — | Filing → |
| ALNY | SELL | 2025-08-19 | $2.0M | — | Filing → |